The results indicated that MCA exhibited specific metabolic signatures and was accompanied by high AD progression signatures (β-secretase activity, γ-secretase activity, NFT, Braak, and the AD-risk gene APOE4). The gene discussed is APOE; the disease is Alzheimer disease.